Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
25.93
+0.66 (2.61%)
May 6, 2026, 11:04 AM EDT - Market open
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 15 analysts that cover Acadia Healthcare Company stock have a consensus rating of "Buy" and an average price target of $24.67, which forecasts a -4.86% decrease in the stock price over the next year. The lowest target is $13 and the highest is $31.
Price Target: $24.67 (-4.86%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 4 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 5 | 6 | 5 | 6 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +19.55% | May 4, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $26 → $31 | Strong Buy | Maintains | $26 → $31 | +19.55% | May 4, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $20 → $30 | Hold | Maintains | $20 → $30 | +15.70% | May 1, 2026 |
| Barclays | Barclays | Hold Maintains $20 → $25 | Hold | Maintains | $20 → $25 | -3.59% | May 1, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $24 → $30 | Strong Buy | Maintains | $24 → $30 | +15.70% | Apr 28, 2026 |
Financial Forecast
Revenue This Year
3.48B
from 3.31B
Increased by 4.96%
Revenue Next Year
3.69B
from 3.48B
Increased by 6.01%
EPS This Year
1.53
from -12.16
EPS Next Year
1.73
from 1.53
Increased by 13.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.6B | 3.9B | ||
| Avg | 3.5B | 3.7B | ||
| Low | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 9.2% | 11.5% | ||
| Avg | 5.0% | 6.0% | ||
| Low | -0.1% | -0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.74 | 2.00 | ||
| Avg | 1.53 | 1.73 | ||
| Low | 1.40 | 1.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 30.7% | ||
| Avg | - | 13.6% | ||
| Low | - | -3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.